NTRR (Neutra) FCF Margin % : -3.13% (As of Apr. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Neutra FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Neutra's Free Cash Flow for the three months ended in Apr. 2024 was $-0.00 Mil. Neutra's Revenue for the three months ended in Apr. 2024 was $0.03 Mil. Therefore, Neutra's FCF Margin % for the quarter that ended in Apr. 2024 was -3.13%.

As of today, Neutra's current FCF Yield % is -0.34%.

The historical rank and industry rank for Neutra's FCF Margin % or its related term are showing as below:

NTRR' s FCF Margin % Range Over the Past 10 Years
Min: -6080 Med: -484.78 Max: -3.08
Current: -3.08

During the past 13 years, the highest FCF Margin % of Neutra was -3.08%. The lowest was -6080.00%. And the median was -484.78%.

NTRR's FCF Margin % is ranked worse than
62.65% of 980 companies
in the Drug Manufacturers industry
Industry Median: 0.87 vs NTRR: -3.08

Neutra FCF Margin % Historical Data

The historical data trend for Neutra's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra FCF Margin % Chart

Neutra Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

FCF Margin %

Get a 7-Day Free Trial

-3,033.33

-6,080.00

-484.78

-225.00

-25.00

Neutra Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
FCF Margin %	Get a 7-Day Free Trial															-150.00	-50.00	-	3.57	-3.13

Competitive Comparison of Neutra's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Neutra's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neutra's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neutra's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Neutra's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Neutra FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Neutra's FCF Margin for the fiscal year that ended in Jan. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jan. 2024 )	/	Revenue (A: Jan. 2024 )
	=	-0.01	/	0.04
	=	-25.00 %

Neutra's FCF Margin for the quarter that ended in Apr. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Apr. 2024 )	/	Revenue (Q: Apr. 2024 )
	=	-0.001	/	0.032
	=	-3.13 %

Neutra FCF Margin % Related Terms

Thank you for viewing the detailed overview of Neutra's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Neutra Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neutra Corp (OTCPK:NTRR) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2500 CityWest Boulevard, Suite 150-161, Houston, TX, USA, 77042

Website

https://www.neutrainc.com

Neutra Corp is a research and development company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. It sells hemp-derived products, including products containing delta-8-THC and other cannabinoids. Geographically, all the activities are operated through the region of the United States.

Executives

Sydney Jim

director, officer: CEO & Chairman

8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243